Table of Contents What Cagrilintide and Retatrutide Are and How They Work Approved Uses and Current Clinical Evidence in the UK How These Medicines May Affect Men Specifically Dosage, Administration, and What to Expect Side Effects, Risks, and Safety Considerations Availability on the NHS and Next Steps for Treatment Scientific References Frequently Asked Questions What Cagrilintide and Retatrutide Are and How They Work Cagrilintide is a long-acting amylin analogue that promotes satiety and slows gastric emptying, while retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors to reduce appetite, enhance insulin secretion, and increase energy expenditure
Beneficial for Specific Groups: People with conditions like pernicious anemia, celiac disease, atrophic gastritis, or those whove undergone certain surgeries, may not absorb B12 well through the stomach and hence benefit from shots
[248], when an absorbable collagen type I sponge functionalized with a synthetic collagen-targeted RGD containing low doses of BMP-2, ectopic bone formation was observed in rats
Conditions that are more comparable with the general population are often more poorly controlled
